EN DE

WON TECH Co (336570) Fair Value & Analysis

Healthcare · KR · Market cap 449B KRW

WT WON TECH Co 336570 · KQ
Price5,330 KRW
Fair Value4,322 KRW
Upside-18.9%
Quality78/100
Watch WON TECH Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Highly profitable · 21.1% net margin
Low debt · generates free cash flow
1.00% dividend yield
Ranks above peers (9/10)
Wide moat 83/100
Evidence: High Range 3,042 KRW – 17,287 KRW Share as image

Fair value as of: Jul 22, 2026

From 26 valuation models · updated 19 days ago

Fair value updated Jul 22, 2026, revised from 4,357 KRW to 4,322 KRW (−0.8%) since Jul 9, 2026. Share price −7.1% over the past month.

A strong business, but screening 19% overvalued on our models.

What matters now

  • A high-quality business (quality 78/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The model range is unusually wide (3,042 KRW to 17,287 KRW). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

14,586 KRW 1,959 KRW Fair Value 4,322 KRW Sep 2020 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range 1,959 KRW – 14,586 KRW · fair‑value band 3,042 KRW – 17,287 KRW · the 5,330 KRW price screens above the 4,322 KRW fair value. Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

WON TECH Co (336570) currently trades at 5,330 KRW, while our model-based Fair Value estimate is 4,322 KRW, implying the stock looks roughly 18.9% overvalued today. The Quality Score stands at 78/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, WON TECH Co generated revenue of 160B KRW at a net margin of 21.1%. Revenue grew 7.6% year over year. It earns a return on equity of 22.7%. Net debt stands at 4.5B KRW. Fundamentals as of Jul 22, 2026

Our scenario range runs from 3,042 KRW (bear case) to 17,287 KRW (bull case); at 5,330 KRW, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 60% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -26% fair-value upside, at -19%, 336570 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 9,814 KRW 20,059 KRW 37,265 KRW 80
Residual Income 2,929 KRW 4,150 KRW 29,215 KRW 76
Rev-Margin DCF 4,436 KRW 6,764 KRW 11,485 KRW 74
All 26 models by family
DCF Models
FCF DCF 10,390 KRW 16,530 KRW 36,607 KRW 38
Owner Earnings 7,267 KRW 16,538 KRW 36,872 KRW 31
5Y Revenue Exit 4,215 KRW 5,941 KRW 9,463 KRW 39
5Y EBITDA Exit 5,125 KRW 7,782 KRW 12,955 KRW 41
5Y P/E Exit 6,205 KRW 12,229 KRW 20,235 KRW 38
10Y Revenue Exit 5,939 KRW 10,079 KRW 11,910 KRW 36
10Y EBITDA Exit 6,689 KRW 12,085 KRW 20,724 KRW 37
10Y P/E Exit 7,496 KRW 14,468 KRW 25,456 KRW 35
Earnings-Based
Graham-Dodd 2,699 KRW 18,824 KRW 26,416 KRW 54
Lynch FV 8,497 KRW 12,138 KRW 15,780 KRW 50
PEG = 1.0 8,497 KRW 12,138 KRW 15,780 KRW 46
EPV 5,607 KRW 6,532 KRW 7,354 KRW 59
Dividend Discount
Gordon GGM 482.33 KRW 1,053 KRW 1,772 KRW 70
DDM Multi-Stage 482.33 KRW 862.58 KRW 1,097 KRW 61
Multiples
P/E Multiple 4,168 KRW 5,557 KRW 6,946 KRW 63
P/S Multiple 1,591 KRW 2,121 KRW 2,651 KRW 58
P/B Multiple 2,394 KRW 3,193 KRW 3,991 KRW 55
EV/EBIT 4,733 KRW 6,189 KRW 7,645 KRW 53
EV/EBITDA 3,133 KRW 4,056 KRW 4,979 KRW 54
EV/Revenue 1,849 KRW 2,485 KRW 3,122 KRW 43
Asset-Based
NCAV (Graham) 886.81 KRW 1,188 KRW 1,774 KRW 50
Growth DCF
Growth DCF 9,814 KRW 20,059 KRW 37,265 KRW 80
Rev-Margin DCF 4,436 KRW 6,764 KRW 11,485 KRW 74
Economic Profit
Residual Income 2,929 KRW 4,150 KRW 29,215 KRW 76
ROIC Compounder 7,324 KRW 11,335 KRW 16,999 KRW 72
Growth Earnings
Growth-Adj P/E 10,155 KRW 14,507 KRW 18,859 KRW 68

Widest divergence: Growth Earnings (14,507 KRW) versus Dividend Discount (862.58 KRW). Highest evidence: Growth DCF (80).

Notify me when 336570 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 160B KRW
Revenue growth (YoY) +7.6%
Net margin 21.1%
Return on equity 22.7%
Free cash flow 49.8B KRW FY2025
Operating margin 27.8%
More key figures
Dividend yield 1.0%
EPS growth (YoY) -13.5%
Net debt 4.5B KRW FY2023

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 78/100

Of which business quality 78 · Market factors (momentum, volatility) 14

Profitability 80
Margins and returns on capital today
Quality Growth 79
Are margins and returns improving?
Cashflow 91
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 37
Calm price path (market factor)
Momentum 6
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 74
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

WON TECH Co.,Ltd. engages in the production and sale of laser and energy-based equipment in South Korea and internationally. The company offers aesthetics, skincare, homecare, and surgical usage equipment.

Full company description

WON TECH Co.,Ltd. engages in the production and sale of laser and energy-based equipment in South Korea and internationally. The company offers aesthetics, skincare, homecare, and surgical usage equipment. It also provides products for the treatments, including face lifting and tightening, body contouring, skin rejuvenation, tattoo removal, scars and striae, vascular lesions, hair removal, and surgical. The company was formerly known as WONTECHnology and changed its name to WON TECH Co.,Ltd. in 2013. WON TECH Co.,Ltd. was founded in 1999 and is headquartered in Daejeon, South Korea.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

WON TECH Co reported revenue of 157B KRW in FY2025 versus 51.1B KRW in FY2021, a compound +32.4%/yr. Reported net income was 35.2B KRW in FY2025.

Growth Quality 90/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
157B KRW
Latest YoY
+36.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+24.4%
Revenue +32.4%/yr
FY21 51.1B KRW
FY22 81.5B KRW
FY23 116B KRW
FY24 115B KRW
FY25 157B KRW
Net income
FY21 −36.1M KRW
FY22 13.4B KRW
FY23 38.8B KRW
FY24 29.1B KRW
FY25 35.2B KRW

336570 screens 19% overvalued. Compare with Abbott Laboratories, →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "WON TECH Co Fair Value". https://www.fairvalue-calculator.com/stock/336570

Peer Group

Medical Devices · 352 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 78 · Top 25%
Fair Value upside −19% · Above median
Return on equity (TTM) 23% · Top 25%
Return on assets 14% · Top 25%
Net margin (TTM) 21% · Top 25%
Operating margin (TTM) 28% · Top 25%
Revenue growth 8% · Above median
Dividend yield (TTM) 1.0% · Below median
Debt / equity 0.00× · Lower than 75% of peers

Valuation Multiples vs Medical Devices median · lower = cheaper

P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 8 · sector 0
FUTURE 38 · sector 29
PAST 91 · sector 8
HEALTH 100 · sector 97
DIVIDEND 20 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $100.68 $74.79 -26%
Stryker Corporation SYK $316.44 $186.28 -41%
Medtronic plc MDT $83.56 $65.57 -22%
Boston Scientific Corporation BSX $43.04 $38.44 -11%
Edwards Lifesciences Corporation EW $85.73 $41.02 -52%
Siemens Healthineers AG SHL €34.59 €33.87 -2%
DexCom, Inc DXCM $74.96 $38.95 -48%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥149.43 ¥147.63 -1%
Shanghai United Imaging Healthcare Co 688271 ¥109.00 ¥43.60 -60%
Demant A/S DEMANT kr 276.60 kr 161.17 -42%

Compare WON TECH Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is WON TECH Co (336570) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of 4,322 KRW versus a price of 5,330 KRW, about −19% (overvalued).
What is the fair value of 336570?
Our model-based fair value for WON TECH Co is 4,322 KRW (as of Jul 22, 2026), built from audited fundamentals. The current price is 5,330 KRW.
What is the quality score of 336570?
WON TECH Co has a Quality Score of 78/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of WON TECH Co (336570)?
WON TECH Co reported trailing-twelve-month revenue of about 160B KRW (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 336570?
The net profit margin of WON TECH Co is about 21.1%, meaning it keeps roughly 21.1% of revenue as net income. Based on the latest reported figures.
Does WON TECH Co pay a dividend?
WON TECH Co currently shows a dividend yield of about 0.67% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track WON TECH Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.